Advanced Biomed is trading 5.9% down at $9.01, primarily amid biotech-sector weakness.
- It closed at $9.57 on August 27, 2026.
- No reliable company-specific announcement, filing, earnings report, or regulatory catalyst has been identified for August 28, 2026.
- Biotech ETF XBI is down 2.31% as investors reduced exposure to higher-risk growth stocks amid uncertainty surrounding Federal Reserve policy and the Jackson Hole speech.